Altered glycogen metabolism in cultured astrocytes from mice with chronic glutathione deficit; relevance for neuroenergetics in schizophrenia

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Lavoie, Suzie ^a   Allaman, Igor ^b   Petit, Jean Marie ^b   Do, Kim Q ^a   Magistretti, Pierre J ^a,b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUTATHIONE; GLYCOGEN; ANTIOXIDANT; CARBON DIOXIDE; GCLM PROTEIN, MOUSE; GLUTAMATE CYSTEINE LIGASE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENERGY METABOLISM; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOGEN METABOLISM; GLYCOGEN SYNTHESIS; MOUSE; NERVE CELL CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN TARGETING; SCHIZOPHRENIA; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; CHRONIC DISEASE; COMPARATIVE STUDY; GENETICS; METABOLISM; MOUSE MUTANT; NERVE DEGENERATION; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

MUS;

ANIMALS; ANTIOXIDANTS; ASTROCYTES; BLOTTING, WESTERN; CARBON DIOXIDE; CELLS, CULTURED; CHRONIC DISEASE; ENERGY METABOLISM; GLUCOSE; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; GLYCOGEN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE DEGENERATION; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 79960872321     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022875     Document Type: Article

References (81)

1. Jou MJ, (2008) Pathophysiological and pharmacological implications of mitochondria-targeted reactive oxygen species generation in astrocytes. Adv Drug Deliv Rev 60: 1512-1526.
2. Halliwell B, Chirico C, (1993) Lipid peroxidation: its mechanism, measurement, and significance. American Journal of Clinical Nutrition 57: 715S-724S.
3. Halliwell B, (1999) Oxygen and nitrogen are pro-carcinogens. Damage to DNA by reactive oxygen, chlorine and nitrogen species: measurement, mechanism and the effects of nutrition. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 443: 37-52.
4. Magistretti PJ, (2008) Brain Energy Metabolism. In: Squire LBD, Bloom Fe, du Lac S, Ghosh A, Spitzer N, editors. Fundamental Neuroscience, 3rd Edition Academic Press pp. 271-293.
5. Dringen R, (2000) Metabolism and functions of glutathione in brain. Progress in Neurobiology 62: 649-671.
6. Orlowski M, Karkowsky A, (1976) Glutathione metabolism and some possible functions of glutathione in the nervous system. Int Rev Neurobiol 19: 75-121.
7. Meister A, Anderson ME, (1983) Glutathione. Annual Review of Biochemistry 52: 711-760.
8. Hammond CL, Lee TK, Ballatori N, (2001) Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes. J Hepatol 34: 946-954.
9. Ursini MV, Parrella A, Rosa G, Salzano S, Martini G, (1997) Enhanced expression of glucose-6-phosphate dehydrogenase in human cells sustaining oxidative stress. Biochem J 323: 801-806.
10. Garcia-Nogales P, Almeida A, Bolanos JP, (2003) Peroxynitrite protects neurons against nitric oxide-mediated apoptosis. A key role for glucose-6-phosphate dehydrogenase activity in neuroprotection. Journal of Biological Chemistry 278: 864-874.
11. Rui B, Shen T, Zhou H, Liu J, Chen J, et al. (2010) A systematic investigation of Escherichia coli central carbon metabolism in response to superoxide stress. BMC Syst Biol 4: 122.
12. Kussmaul L, Hamprecht B, Dringen R, (1999) The Detoxification of Cumene Hydroperoxide by the Glutathione System of Cultured Astroglial Cells Hinges on Hexose Availability for the Regeneration of NADPH. Journal of Neurochemistry 73: 1246-1253.
13. Dringen R, Hamprecht B, (1997) Involvement of glutathione peroxidase and catalase in the disposal of exogenous hydrogen peroxide by cultured astroglial cells. Brain Research 759: 67-75.
14. Pias EK, Aw TY, (2002) Apoptosis in mitotic competent undifferentiated cells is induced by cellular redox imbalance independent of reactive oxygen species production. The FASEB Journal 16: 781-790.
15. Dringen R, Hirrlinger J, (2003) Glutathione pathways in the brain. Biol Chem 384: 505-516.
16. Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, et al. (2009) Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 390: 191-214.
17. Do KQ, Bovet P, Cabungcal JH, Conus P, Gysin R, et al. (2009) Redox dysregulation in schizophrenia: Genetic susceptibility and pathophysiological mechanisms. In: Javitt DC, Kantrowitz JT, editors. Hankbook of neurochemistry and molecular neurobiology. 3rd ed New York- London Springer.
18. Yao JK, Leonard S, Reddy R, (2006) Altered glutathione redox state in schizophrenia. Dis Markers 22: 83-93.
19. Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M, (2009) Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol 19: 220-230.
20. Tosic M, Ott J, Barral S, Bovet P, Deppen P, et al. (2006) Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene. The American Journal of Human Genetics 79: 586-592.
21. Belanger M, Magistretti PJ, (2009) The role of astroglia in neuroprotection. Dialogues Clin Neurosci 11: 281-295.
22. Shih AY, Erb H, Sun X, Toda S, Kalivas PW, et al. (2006) Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. Journal of Neuroscience 26: 10514-10523.
23. Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, et al. (2003) Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. Journal of Neuroscience 23: 3394-3406.
24. Magistretti PJ, (2006) Neuron-glia metabolic coupling and plasticity. Journal of Experimental Biology 209: 2304-2311.
25. Pellerin L, Bouzier-Sore AK, Aubert A, Serres S, Merle M, et al. (2007) Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia 55: 1251-1262.
26. Pellerin L, Magistretti PJ, (1994) Glutamate Uptake into Astrocytes Stimulates Aerobic Glycolysis: A Mechanism Coupling Neuronal Activity to Glucose Utilization. Proceedings of the National Academy of Sciences 91: 10625-10629.
27. Pellerin L, Pellegri G, Bittar P, Charnay Y, Bouras C, et al. (1998) Evidence Supporting the Existence of an Activity-Dependent Astrocyte-Neuron Lactate Shuttle. Dev Neurosci 20: 291-299.
28. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG, (1999) Energy on demand. Science 283: 496-497.
29. Magistretti PJ, Hof PR, Martin JL, (1986) Adenosine stimulates glycogenolysis in mouse cerebral cortex: a possible coupling mechanism between neuronal activity and energy metabolism. J Neurosci 6: 2558-2562.
30. Magistretti PJ, Morrison JH, Shoemaker WJ, Sapin V, Bloom FE, (1981) Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism. Proc Natl Acad Sci U S A 78: 6535-6539.
31. Sorg O, Magistretti PJ, (1991) Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes. Brain Research 563: 227-233.
32. Allaman I, Pellerin L, Magistretti PJ, (2004) Glucocorticoids modulate neurotransmitter-induced glycogen metabolism in cultured cortical astrocytes. Journal of Neurochemistry 88: 900-908.
33. Allaman I, Lengacher S, Magistretti PJ, Pellerin L, (2003) A2B receptor activation promotes glycogen synthesis in astrocytes through modulation of gene expression. Am J Physiol Cell Physiol 284: C696-704.
34. Hof PR, Pascale E, Magistretti PJ, (1988) K+ at concentrations reached in the extracellular space during neuronal activity promotes a Ca2+-dependent glycogen hydrolysis in mouse cerebral cortex. J Neurosci 8: 1922-1928.
35. Sorg O, Pellerin L, Stolz M, Beggah S, Magistretti PJ, (1995) Adenosine triphosphate and arachidonic acid stimulate glycogenolysis in primary cultures of mouse cerebral cortical astrocytes. Neurosci Lett 188: 109-112.
36. Brown AM, Ransom BR, (2007) Astrocyte glycogen and brain energy metabolism. Glia 55: 1263-1271.
37. Wender R, Brown AM, Fern R, Swanson RA, Farrell K, et al. (2000) Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J Neurosci 20: 6804-6810.
38. Gibbs ME, Anderson DG, Hertz L, (2006) Inhibition of glycogenolysis in astrocytes interrupts memory consolidation in young chickens. Glia 54: 214-222.
39. Hertz L, O'Dowd BS, Ng KT, Gibbs ME, (2003) Reciprocal changes in forebrain contents of glycogen and of glutamate/glutamine during early memory consolidation in the day-old chick. Brain Res 994: 226-233.
40. Brown AM, Baltan Tekkok S, Ransom BR, (2004) Energy transfer from astrocytes to axons: the role of CNS glycogen. Neurochem Int 45: 529-536.
41. Brown AM, Tekkok SB, Ransom BR, (2003) Glycogen regulation and functional role in mouse white matter. J Physiol 549: 501-512.
42. Swanson RA, (1992) Physiologic coupling of glial glycogen metabolism to neuronal activity in brain. Can J Physiol Pharmacol 70 (Suppl): S138-144.
43. Sickmann HM, Walls AB, Schousboe A, Bouman SD, Waagepetersen HS, (2009) Functional significance of brain glycogen in sustaining glutamatergic neurotransmission. J Neurochem 109 (Suppl 1): 80-86.
44. Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, et al. (2011) Astrocyte-neuron lactate transport is required for long-term memory formation. Cell In Press.
45. Meister A, (1995) Glutathione biosynthesis and its inhibition. Methods Enzymol 252: 26-30.
46. Anderson ME, (1998) Glutathione: an overview of biosynthesis and modulation. Chemico-Biological Interactions 111-112: 1-14.
47. Lu SC, (2009) Regulation of glutathione synthesis. Mol Aspects Med 30: 42-59.
48. Steullet P, Cabungcal JH, Kulak A, Kraftsik R, Chen Y, et al. (2010) Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors. J Neurosci 30: 2547-2558.
49. Dalton TP, Chen Y, Schneider SN, Nebert DW, Shertzer HG, (2004) Genetically altered mice to evaluate glutathione homeostasis in health and disease. Free Radical Biology & Medicine 37: 1511-1526.
50. Yang Y, Dieter MZ, Chen Y, Shertzer HG, Nebert DW, et al. (2002) Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm (-/-) knockout mouse. Journal of Biological Chemistry 277: 49446-49452.
51. Lavoie S, Chen Y, Dalton TP, Gysin R, Cuenod M, et al. (2009) Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit. J Neurochem 108: 1410-1422.
52. McCarthy KD, de Vellis J, (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. The Journal of Cell Biology 85: 890-902.
53. Allaman I, Gavillet M, Belanger M, Laroche T, Viertl D, et al. (2010) Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci 30: 3326-3338.
54. Do KQ, Benz B, Sorg O, Pellerin L, Magistretti PJ, (1997) beta-Adrenergic Stimulation Promotes Homocysteic Acid Release from Astrocyte Cultures: Evidence for a Role of Astrocytes in the Modulation of Synaptic Transmission. Journal of Neurochemistry 68: 2386-2394.
55. Walls AB, Sickmann HM, Brown A, Bouman SD, Ransom B, et al. (2008) Characterization of 1,4-dideoxy-1,4-imino-d-arabinitol (DAB) as an inhibitor of brain glycogen shunt activity. J Neurochem 105: 1462-1470.
56. Dringen R, Kussmaul L, Hamprecht B, (1998) Rapid clearance of tertiary butyl hydroperoxide by cultured astroglial cells via oxidation of glutathione. Glia 23: 139-145.
57. Pellegri G, Rossier C, Magistretti PJ, Martin JL, (1996) Cloning, localization and induction of mouse brain glycogen synthase. Brain Res Mol Brain Res 38: 191-199.
58. Tietze F, (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Analytical Biochemistry 27: 522.
59. Steullet P, Lavoie S, Kraftsik R, Guidi R, Gysin R, et al. (2008) A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons. Free Radic Biol Med 44: 1042-1054.
60. Griffith OW, (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106: 207-212.
61. Dringen R, Kussmaul L, Hamprecht B, (1998) Detoxification of exogenous hydrogen peroxide and organic hydroperoxides by cultured astroglial cells assessed by microtiter plate assay. Brain Research Protocols 2: 223-228.
62. Allaman I, Pellerin L, Magistretti PJ, (2000) Protein targeting to glycogen mRNA expression is stimulated by noradrenaline in mouse cortical astrocytes. Glia 30: 382-391.
63. Wiesinger H, Hamprecht B, Dringen R, (1997) Metabolic pathways for glucose in astrocytes. Glia 21: 22-34.
64. Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis Cl, et al. (2007) Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence. Proceedings of the National Academy of Sciences 104: 16621-16626.
65. Sorg O, Magistretti PJ, (1992) Vasoactive intestinal peptide and noradrenaline exert long-term control on glycogen levels in astrocytes: blockade by protein synthesis inhibition. Journal of Neuroscience 12: 4923-4931.
66. O'Doherty RM, Jensen PB, Anderson P, Jones JG, Berman HK, et al. (2000) Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen. J Clin Invest 105: 479-488.
67. Printen JA, Brady MJ, Saltiel AR, (1997) PTG, a protein phosphatase 1-binding protein with a role in glycogen metabolism. Science 275: 1475-1478.
68. Crosson SM, Khan A, Printen J, Pessin JE, Saltiel AR, (2003) PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance. J Clin Invest 111: 1423-1432.
69. Cheng A, Zhang M, Crosson SM, Bao ZQ, Saltiel AR, (2006) Regulation of the mouse protein targeting to glycogen (PTG) promoter by the FoxA2 forkhead protein and by 3′,5′-cyclic adenosine 5′-monophosphate in H4IIE hepatoma cells. Endocrinology 147: 3606-3612.
70. Rahman B, Kussmaul L, Hamprecht B, Dringen R, (2000) Glycogen is mobilized during the disposal of peroxides by cultured astroglial cells from rat brain. Neuroscience Letters 290: 169-172.
71. Liddell JR, Zwingmann C, Schmidt MM, Thiessen A, Leibfritz D, et al. (2009) Sustained hydrogen peroxide stress decreases lactate production by cultured astrocytes. J Neurosci Res 87: 2696-2708.
72. Hirrlinger J, Konig J, Keppler D, Lindenau J, Schulz JB, et al. (2001) The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress. Journal of Neurochemistry 76: 627-636.
73. Ben-Yoseph O, Boxer PA, Ross BD, (1996) Assessment of the Role of the Glutathione and Pentose Phosphate Pathways in the Protection of Primary Cerebrocortical Cultures from Oxidative Stress. Journal of Neurochemistry 66: 2329-2337.
74. Yao JK, Keshavan MS, (2011) Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View. Antioxid Redox Signal.
75. Yao JK, Reddy R, (2011) Oxidative Stress in Schizophrenia: Pathogenetic and Therapeutic Implications. Antioxid Redox Signal.
76. Grima G, Benz B, Parpura V, Cuenod M, Do KQ, (2003) Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia. Schizophrenia Research 62: 213-224.
77. Fujimoto T, Takeuch K, Matsumoto T, Kamimura K, Hamada R, et al. (2007) Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia. Psychiatry Res 154: 49-58.
78. Haznedar MM, Buchsbaum MS, Luu C, Hazlett EA, Siegel BV Jr, et al. (1997) Decreased anterior cingulate gyrus metabolic rate in schizophrenia. Am J Psychiatry 154: 682-684.
79. Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, et al. (1992) Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 49: 935-942.
80. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, et al. (1992) Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 49: 522-530.
81. Molina V, Solera S, Sanz J, Sarramea F, Luque R, et al. (2009) Association between cerebral metabolic and structural abnormalities and cognitive performance in schizophrenia. Psychiatry Res 173: 88-93.